Key facts
- This page summarizes Surendra K. Ajjarapu's Form 4 filing for Ocean Biomedical, Inc. (OCEA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 Mar 2023, 21:23.
Surendra K. Ajjarapu - 22 Mar 2023 Form 4 Insider Report for Ocean Biomedical, Inc. (OCEA)
- Reporting relationship
- Director
- Issuer ticker
- OCEA
- Reported as of
- 22 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 Mar 2023, 21:23:08 UTC
- Prior SEC filing
- 21 Apr 2023
- Next SEC filing
- 14 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Katherine E. Spiser, as attorney-in-fact for Surendra K. Ajjarapu
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Surendra K. Ajjarapu filed Form 4 for Ocean Biomedical, Inc. (OCEA) on 24 Mar 2023.
Change
- Previous filing in this sequence was filed on 21 Apr 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OCEA
transaction
Common Stock, par value $0.0001
Other
- Transaction value
- Shares
- -1,050,000
- Change %
- -77%
- Price
- Shares after
- 315,000
- Date
- 22 Mar 2023
- Ownership
- By Aesther Healthcare Sponsor, LLC
- Footnotes
- F1, F2
OCEA
holding
Common Stock, par value $0.0001
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 21,252
- Date
- 22 Mar 2023
- Ownership
- By Sansur Associates, LLC
- Footnotes
- F3
OCEA
holding
Common Stock, par value $0.0001
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 469,300
- Date
- 22 Mar 2023
- Ownership
- By Surendra Ajjarapu Revocable Trust of 2007
- Footnotes
- F4
OCEA
holding
Common Stock, par value $0.0001
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 258,200
- Date
- 22 Mar 2023
- Ownership
- By Sandhya Ajjarapu Revocable Trust of 2007
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents the transfer of 1,050,000 shares of common stock, par value $0.0001 per share (the "Common Stock"), of Ocean Biomedical, Inc. (the "Issuer") from Aesther Healthcare Sponsor, LLC (the "Sponsor") to NPIC Limited (the "Lender") on March 22, 2023 pursuant to that certain Loan Modification Agreement, dated March 22, 2023, between the Sponsor, the Issuer, and the Lender, as consideration for the Lender's agreement to extend the maturity date of the Sponsor's repayment of a $1,050,000 loan.
Footnote F2
These shares of Common Stock are owned directly by the Sponsor. Suren Ajjarapu ("Mr. Ajjarapu") is the managing member of the Sponsor and therefore may be deemed to have beneficial ownership of the securities held by the Sponsor. Mr. Ajjarapu disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Footnote F3
These shares of Common Stock are owned directly by Sansur Associates, LLC ("Sansur"). As manager of Sansur, Mr. Ajjarapu may be deemed to be the indirect beneficial owner of the securities held by Sansur. Mr. Ajjarapu disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Footnote F4
These shares are owned directly by the Surendra Ajjarapu Revocable Trust of 2007 (the "Surendra Trust"). As trustee of the Surendra Trust, Mr. Ajjarapu may be deemed to be the indirect beneficial owner of the securities held by the Surendra Trust. Mr. Ajjarapu disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Footnote F5
These shares of Common Stock are owned directly by the Sandhya Ajjarapu Revocable Trust of 2007 (the "Sandhya Trust"), of which Mr. Ajjarapu's wife, Sandhya Ajjarapu ("Mrs. Ajjarapu") is the trustee and Mr. Ajjarapu is the successor trustee. Because Mrs. Ajjarapu's pecuniary interest in the Sandhya Trust is attributable to Mr. Ajjarapu by nature of their spousal relationship, Mr. Ajjarapu may be deemed to be the indirect beneficial owner of the securities held by the Sandhya Trust. Mr. Ajjarapu disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
SEC remarks
Exhibit List - Exhibit 24.1: Power of Attorney (Surendra K. Ajjarapu)